Vaccine, EU: no export authorization will be needed from January

• Von der Leyen: EU world leader in vaccinations

• Vaccines: EU-AstraZeneca agreement, legal dispute ends

• Vaccines, the EU signs a contract with Novavax for 200 million doses

Share

November 26, 2021 "The EU will replace the export authorization mechanism for vaccines against Covid-19, which expires on December 31 of this year, with a new monitoring tool. This means that from January 1, 2022, producers of vaccines will no longer have to apply for an authorization to export vaccines outside the EU ". This was announced by Dana Spinant, spokesperson for the European Commission, in the daily press briefing. "Export transparency will continue to be ensured through this new monitoring mechanism which will provide the Commission with timely and specific data on vaccine exports for each company," Spinant added. "The EU - he concluded - is the largest global supplier of vaccines" with "over 1,3 billion doses exported so far since December to more than 150 countries ".

"We must remain very vigilant regarding this new variant" of the virus, "It is good that member states are acting quickly to take appropriate measures," said Dana. Spinant, one of the spokespersons of the European Commission.